{"title_page": "Ethacridine lactate", "text_new": "{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 477162867\n| IUPAC_name = 7-Ethoxyacridine-3,9-diamine  2-hydroxypropanoic acid\n| image = Ethacridinlactat.svg\n| alt =  Skeletal formulas of ethacridine lactate\n| image2 = Ethacridine lactate 3D spacefill.png\n| alt2 = Ball-and-stick models of the component ions of ethacridine lactate\n\n<!--Clinical data-->\n| tradename =  \n| Drugs.com = {{drugs.com|international|ethacridine-lactate}}\n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category =  \n| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->\n| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->\n| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->\n| legal_status =  \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|changed|??}}\n| CAS_number = 1837-57-6\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 7T7T2I9823\n| ATCvet =  \n| ATC_prefix = B05\n| ATC_suffix = CA08\n| ATC_supplemental = {{ATC|D08|AA01}}\n| PubChem = 15789\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank =  \n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 15012\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = D01248\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 582355\n\n<!--Chemical data-->\n| C=18 | H=21 | N=3 | O=4 \n| molecular_weight = 343.37\n| smiles = O=C(O)C(O)C.O(c2ccc1nc3c(c(c1c2)N)ccc(c3)N)CC\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C15H15N3O.C3H6O3/c1-2-19-10-4-6-13-12(8-10)15(17)11-5-3-9(16)7-14(11)18-13;1-2(4)3(5)6/h3-8H,2,16H2,1H3,(H2,17,18);2,4H,1H3,(H,5,6)\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = IYLLULUTZPKQBW-UHFFFAOYSA-N\n}}\n\n'''Ethacridine lactate''' (ethacridine monolactate monohydrate, '''acrinol''', [[trade name]] '''Rivanol''') is an [[aromatic]] [[organic compound]] based on [[acridine]]. Its formal name is 2-ethoxy-6,9-diaminoacridine monolactate monohydrate.  It forms orange-yellow crystals with a melting point of 226 \u00b0C and it has a stinging smell.\n\nIts primary use is as an [[antiseptic]]<ref>Merck Index, 11th Ed., 3668</ref> in solutions of 0.1%. It is effective against mostly [[Gram-positive bacteria]], such as ''[[Streptococci]]'' and ''[[Staphylococci]]'', but ineffective against [[Gram-negative bacteria]] such as ''[[Pseudomonas aeruginosa]]''.<ref>{{cite journal |vauthors=Adarchenko AA, Krasil'nikov AP, Sobeshchuk OP |title=[Antiseptic sensitivity of clinical strains of Pseudomonas aeruginosa] |language=Russian |journal=Antibiotiki I Khimioterapiia |volume=34 |issue=12 |pages=902\u20137 |year=1989 |pmid=2517004 }}</ref>\n\nEthacridine is also used as an agent for second trimester abortion.  Up to 150 ml of a 0.1% solution is instilled extra-amniotically using a [[foley catheter]]. After 20 to 40 hours, 'mini labor' ensues.  In China, an intra-amniotic method has also been used.<ref>{{Cite journal \n| last1 = Tien | first1 = K. H. \n| title = Intraamniotic injection of ethacridine for second-trimester induction of labor \n| journal = Obstetrics and Gynecology \n| volume = 61 \n| issue = 6 \n| pages = 733\u2013736 \n| year = 1983 \n| pmid = 6843933\n}}</ref>  Ethacridine as an abortifacient is found to be safer and better tolerated than 20% hypertonic saline.\n\n== References ==\n{{reflist}}\n\n\n{{Antiseptics and disinfectants}}\n\n[[Category:Antiseptics]]\n[[Category:Lactates]]\n[[Category:Acridines]]\n[[Category:Phenol ethers]]\n[[Category:Aromatic amines]]\n", "text_old": "{{Drugbox\n| Verifiedfields = changed\n| Watchedfields = changed\n| verifiedrevid = 477162867\n| IUPAC_name = 7-Ethoxyacridine-3,9-diamine  2-hydroxypropanoic acid\n| image = Ethacridinlactat.svg\n| alt =  Skeletal formulas of ethacridine lactate\n| image2 = Ethacridine lactate 3D spacefill.png\n| alt2 = Ball-and-stick models of the component ions of ethacridine lactate\n\n<!--Clinical data-->\n| tradename =  \n| Drugs.com = {{drugs.com|international|ethacridine-lactate}}\n| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->\n| pregnancy_US = <!-- A / B            / C / D / X -->\n| pregnancy_category =  \n| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->\n| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->\n| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->\n| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->\n| legal_status =  \n| routes_of_administration =  \n\n<!--Pharmacokinetic data-->\n| bioavailability =  \n| protein_bound =  \n| metabolism =  \n| elimination_half-life =  \n| excretion =  \n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|changed|??}}\n| CAS_number = 1837-57-6\n| ATCvet =  \n| ATC_prefix = B05\n| ATC_suffix = CA08\n| ATC_supplemental = {{ATC|D08|AA01}}\n| PubChem = 15789\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank =  \n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 15012\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = D01248\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 582355\n\n<!--Chemical data-->\n| C=18 | H=21 | N=3 | O=4 \n| molecular_weight = 343.37\n| smiles = O=C(O)C(O)C.O(c2ccc1nc3c(c(c1c2)N)ccc(c3)N)CC\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C15H15N3O.C3H6O3/c1-2-19-10-4-6-13-12(8-10)15(17)11-5-3-9(16)7-14(11)18-13;1-2(4)3(5)6/h3-8H,2,16H2,1H3,(H2,17,18);2,4H,1H3,(H,5,6)\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = IYLLULUTZPKQBW-UHFFFAOYSA-N\n}}\n\n'''Ethacridine lactate''' (ethacridine monolactate monohydrate, '''acrinol''', [[trade name]] '''Rivanol''') is an [[aromatic]] [[organic compound]] based on [[acridine]]. Its formal name is 2-ethoxy-6,9-diaminoacridine monolactate monohydrate.  It forms orange-yellow crystals with a melting point of 226 \u00b0C and it has a stinging smell.\n\nIts primary use is as an [[antiseptic]]<ref>Merck Index, 11th Ed., 3668</ref> in solutions of 0.1%. It is effective against mostly [[Gram-positive bacteria]], such as ''[[Streptococci]]'' and ''[[Staphylococci]]'', but ineffective against [[Gram-negative bacteria]] such as ''[[Pseudomonas aeruginosa]]''.<ref>{{cite journal |vauthors=Adarchenko AA, Krasil'nikov AP, Sobeshchuk OP |title=[Antiseptic sensitivity of clinical strains of Pseudomonas aeruginosa] |language=Russian |journal=Antibiotiki I Khimioterapiia |volume=34 |issue=12 |pages=902\u20137 |year=1989 |pmid=2517004 }}</ref>\n\nEthacridine is also used as an agent for second trimester abortion.  Up to 150 ml of a 0.1% solution is instilled extra-amniotically using a [[foley catheter]]. After 20 to 40 hours, 'mini labor' ensues.  In China, an intra-amniotic method has also been used.<ref>{{Cite journal \n| last1 = Tien | first1 = K. H. \n| title = Intraamniotic injection of ethacridine for second-trimester induction of labor \n| journal = Obstetrics and Gynecology \n| volume = 61 \n| issue = 6 \n| pages = 733\u2013736 \n| year = 1983 \n| pmid = 6843933\n}}</ref>  Ethacridine as an abortifacient is found to be safer and better tolerated than 20% hypertonic saline.\n\n== References ==\n{{reflist}}\n\n\n{{Antiseptics and disinfectants}}\n\n[[Category:Antiseptics]]\n[[Category:Lactates]]\n[[Category:Acridines]]\n[[Category:Phenol ethers]]\n[[Category:Aromatic amines]]\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Ethacridine_lactate"}
